Navigation Links
Explore the Secrets of Lean Pharma Leadership in Two Live Interactive Video Chats on CPhI PharmaEvolution.com
Date:11/18/2013

NEW YORK, Nov. 18, 2013 /PRNewswire/ -- On Monday, Nov. 25, 2013 at 10:00 a.m. ET/7:00 a.m. PT and Tuesday, Nov. 26, 2013, at 10:00 a.m. ET/7:00 a.m. PT, CPhI PharmaEvolution.com will host two live interactive video chats on Lean and Operational Excellence practices. Thomas Friedli, a professor at the University of St. Gallen's Institute of Technology Management, will be the special guest for the first chat. William Botha, an expert on Lean and Toyota Production System (TPS) techniques, will speak during the second program.

Rapid change and increased complexity have made it more important, and more challenging, than ever to drive operational excellence within the global pharmaceutical industry. The guest speakers will explore how some of pharma's most effective managers are embracing the principles of Deming, Juran, and Toyota to create continuous improvement cultures.

On Monday, Nov. 25, Thomas Friedli, a professor at the University of St. Gallen's Institute of Technology Management, will share examples of Lean manufacturing leadership and best-practices in the pharmaceutical industry, including tips on how to support and lead these efforts. He will also discuss his new book on this topic.

On Tuesday, Nov. 26, William Botha, who has held senior management positions and has led Kaizen and other initiatives at Baxter and other companies within and outside the pharma industry, will share best-practices for creating a sustainable change culture, projecting leadership values and vision, and communicating and adapting change tools to your operations.

For more information and to participate in the live video chat with Professor Friedli on Monday, Nov. 25, visit
http://www.pharmaevolution.com/video-stream.asp?section_id=3043&doc_id=561813&piddl_promo=127&cid=pr.

For more information and to participate in the live video chat with Mr. Botha on Tuesday, Nov. 26, visit
http://www.pharmaevolution.com/video-stream.asp?section_id=3043&doc_id=561814&piddl_promo=126&cid=pr.

CPhI PharmaEvolution.com (www.pharmaevolution.com) is a partnership involving UBM DeusM, UBM CPhI, and UBM Live.  DeusM specializes in building and operating engaged communities of qualified users within specialized B2B markets. CPhI and UBM Live are leading providers of conferences and expositions that serve the pharmaceutical and other industries.

Contact: 
Carly Cohen
Marketing Coordinator, UBM DeusM
cohen@deusm.com

About UBM DeusM
UBM DeusM (www.deusm.com) is an integrated marketing services company owned by UBM plc, targeting the fastest growing segment of the online publishing industry: business social media. The company is led by Managing Director Stephen Saunders, Min's Marketer of the Year 2010. He and the other UBM DeusM principals have built and delivered more than 45 successful sites and online communities over the last two years. UBM DeusM's service is based on a unique platform, called Community in a Box (CiaB), which employs a structured system of proven B2B web publishing best-practices, combined with a breakthrough integrated multimedia publishing platform ("n-Server") to enable marketers to set up specialized communities quickly and profitably for their target customers.

About CPhI
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences, and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities, and expand the global market. CPhI hosts events in Europe, China, India, Japan, Southeast Asia, Russia, Istanbul, and South America co-located with ICSE for contract services; P-MEC for machinery, equipment, and technology; InnoPack for pharmaceutical packaging; and BioPh for biopharma. CPhI provides an online buyer and supplier directory at CPhI-Online.com and hosts a global community with news and analysis at PharmaEvolution.com.

About UBM plc
UBM plc is a leading global business media company. We inform markets and bring the world's buyers and sellers together at events, online, and in print and provide them with the information they need to do business successfully. We focus on serving professional commercial communities, from doctors to game developers, from journalists to jewelry traders, and from farmers to pharmacists around the world. Our 6,000 staff members in more than 30 countries are organized into specialist teams that serve these communities, helping them to do business and their markets to work effectively and efficiently. For more information, go to www.ubm.com.


'/>"/>
SOURCE CPhI PharmaEvolution
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Explores Medical Affairs Capabilities in Mature and High-Growth Markets
2. Parents May Have Even More Reason to Explore Weight Loss Surgery, suggests Beverly Hills Physicians
3. CoMentis and Anvyl Announce Formation of Alpharmagen, a Joint Venture to explore Nicotinic Modulators
4. Discovery Labs Presents Final Assessment in a Series of Pharmacoeconomic Analyses that Explore Impact of Reintubation on Healthcare Costs
5. Partnership Formed to Explore Personalized Medicine Approach for Amyotrophic Lateral Sclerosis (ALS) Treatments
6. Rutgers Business School and the Blanche and Irwin Lerner Center will explore trends and issues facing the biopharmaceutical industry at a healthcare symposium, Tuesday, April 30
7. Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent
8. Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
9. Imalux Corporation Engages Advisor to Explore Strategic Options
10. Alliqua to Explore Business Development Efforts for Hydrogel Transdermal Delivery Platform in the Cosmeceutical Industry
11. MediSapiens Launches OncoGenomics Explorer, First-in-Kind Cloud Computing Application for Personalized Genomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):